AMPHIPATISCHES PEPTID

European patent · EP3415525 · In force

Register entry

Publication number
EP3415525
Application number
EP18186186
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 9, 2013
Published
Dec 19, 2018
Granted
Jan 5, 2022
Protection ends at the latest
Dec 8, 2033
Next annual fee due
Dec 31, 2026
IPC classes
C07K 14/00 (2006.01)
A61K 48/00 (2006.01)
Priority
GB 201222041 07.12.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jun 6, 2025

    Change

    Published in Swissreg on 06.06.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Nov 16, 2022

    Change

    Published in Swissreg on 16.11.2022

  6. Mar 8, 2022

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 08.03.2022

  7. Jan 5, 2022

    Granted

    Published in Swissreg on 05.01.2022

Parties

Holder

Phion Therapeutics Limited

63 University Road,, Belfast, BT7 1NF, GB

Agent

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventor

ROBSON, Tracy

Belfast, Staffordshire BT9 7BL, GB

ZHOLOBENKO, Aleksey

Larchwood, Staffordshire ST5 5BB, GB

McCARTHY, Helen

Belfast, Staffordshire BT9 7BL, GB

DAVISON, Ashley

Belfast, Staffordshire BT7 3GB, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.